These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Assessment and prevention of gastrointestinal toxicity of non-steroidal anti-inflammatory drugs. Lane ME; Kim MJ J Pharm Pharmacol; 2006 Oct; 58(10):1295-304. PubMed ID: 17034651 [TBL] [Abstract][Full Text] [Related]
5. [Preventive therapy with H2 blockers in patients using steroids and nonsteroidal anti-inflammatory drugs]. Abramovich D; Scapa E; Broide E; Eshchar J Harefuah; 1994 Mar; 126(5):271-3. PubMed ID: 7910573 [No Abstract] [Full Text] [Related]
6. [Nonsteroidal anti-inflammatory agents and gastrointestinal pathology]. Lanas AI Gastroenterol Hepatol; 1995 Mar; 18(3):142-52. PubMed ID: 7621292 [No Abstract] [Full Text] [Related]
7. Gastrointestinal events related to the use of non-steroidal anti-inflammatory drugs: some clinical and economic aspects. Eliakim R; Rachmilewitz D Isr J Med Sci; 1997 Oct; 33(10):696-9. PubMed ID: 9397147 [No Abstract] [Full Text] [Related]
8. Management of non steroidal anti-inflammatory drug induced gastro-intestinal damage. McCormack PM Ir Med J; 1994; 87(2):27-8. PubMed ID: 8194941 [No Abstract] [Full Text] [Related]
9. Over-the-counter nonsteroidal anti-inflammatory drugs and risk of gastrointestinal symptoms. Sangha S; Oviedo JA Am J Gastroenterol; 2003 May; 98(5):1203-4; author reply 1204. PubMed ID: 12809852 [No Abstract] [Full Text] [Related]
14. [Epidemiology of lesions caused by non-steroidal anti-inflammatory agents]. De Angelis C; Rizzetto M; Pera A Minerva Gastroenterol Dietol; 1992; 38(1):27-40. PubMed ID: 1520751 [No Abstract] [Full Text] [Related]
15. [Side effects of treatment with non-steroidal antiinflammatory agents and ways of their corrections]. Grebneva LS; Nasonova SV; Tsvetkov LI Klin Med (Mosk); 1997; 75(5):42-5. PubMed ID: 9235408 [No Abstract] [Full Text] [Related]
16. [The gastrointestinal risk of antiplatelet agents and nonsteroidal anti-inflammatory agents. A report of the American College of Cardiology Foundation (ACCF), the American College of Gastroenterology (ACG) and the American Heart Association (AHA)]. Recenti Prog Med; 2009 May; 100(5):277-8. PubMed ID: 19772220 [No Abstract] [Full Text] [Related]
17. The management of NSAIDs therapy: how to minimize upper gastrointestinal tract damage. Lisotti A; Grenci C; Caponi A; Roda E Minerva Gastroenterol Dietol; 2008 Dec; 54(4):323-9. PubMed ID: 19047972 [No Abstract] [Full Text] [Related]
18. [Prevention of vascular thrombosis and risk of gastrointestinal complications]. Karateev AE; Nasonov EL Ter Arkh; 2007; 79(5):84-9. PubMed ID: 17672083 [No Abstract] [Full Text] [Related]
19. Ulcers from NSAIDs can be prevented. Health News; 2004 Mar; 10(3):11. PubMed ID: 15017941 [No Abstract] [Full Text] [Related]
20. Balancing risks and benefits of cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs. Scheiman JM Gastroenterol Clin North Am; 2009 Jun; 38(2):305-14. PubMed ID: 19446260 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]